Aptamer immune stimulator conjugate - Aptamer sciences
Alternative Names: ApIS - Aptamer SciencesLatest Information Update: 03 May 2024
At a glance
- Originator Aptamer Sciences
- Class Antineoplastics; Drug conjugates; Oligonucleotides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 18 Apr 2024 Early research in Cancer in South Korea (parenteral) prior to April 2024 (Aptamer Sciences pipeline, April 2024)